Celebration for Life is an annual event chaired by Judy and Steve Tuckerman to benefit The James Fund for Life, an annual fund that was established by Abigail and Les Wexner.
More than $15.3 million has been raised for The James Fund for Life since it was established in 2002.
Past Annual Fund Acquisitions
2015 NextSeq 500 Sequencing System
Cancer is the uncontrolled growth of cells that invade and destroy neighboring tissues. If left unchecked, cancer cells can spread to other areas of the body. The fundamental cause of cancer is changes in genes, particularly gene mutations. Understanding these changes is critical for learning how cancer begins, grows and spreads. This knowledge also helps researchers develop ways to treat cancer, to identify patients who will respond to treatments, to help patients overcome treatment resistance, and to determine patients’ chances for recovery. A vital technology for discerning and studying these changes is called next generation sequencing (NGS), a process for identifying the chemical building blocks of a person’s DNA in the order, or sequence, in which they occur within genes in cancer cells and healthy cells.
Revenue generated by Celebration for Life 2015 will help the OSUCCC – James keep pace with advances in NGS technology by supporting the purchase of a NextSeq™ 500 Sequencing System from a California-based company called Illumina. Researchers at the OSUCCC – James chose this instrument because it’s a fast, flexible, high-capacity, desktop gene sequencer that is highly accurate and offers a range of applications. The system’s push-button operation and streamlined process will allow researchers to conduct the most needed sequencing applications in less than a day. By helping researchers analyze patient samples faster than current technology allows, and with similar accuracy, the NextSeq 500 will accelerate the development of treatments that target each patient’s biologically unique cancer.
2009 – 2014 Technology Acquisition Fund
Funding for technology in the new James Cancer Hospital and Solove Research Institute.
2008 Flow Cytometer
This sophisticated instrument enables medical scientists to rapidly measure physical and chemical properties of cells and particles. Flow cytometers, which consist of electrical, digital and optical components, allow for accurate analysis of DNA, cell cycle, cell function and cell death. This analysis is of paramount importance in helping scientists understand the basic properties of cancer in its many forms — insight that translates to innovative treatment at the OSUCCC – James. In 2008, a new Technology Acquisition Fund was created to support the attainment of equipment for the new James Cancer Hospital and Solove Research Institute.
2007 Digital Mobile Mammography Unit & Funds for Technology Needs of the New Survivorship Center
The addition of this new, high-tech mobile unit with digital mammogram capabilities to the JamesCare comprehensive breast program greatly enhances our ability to identify and treat breast cancer in the Columbus region and provides the opportunity to reach areas of Ohio that do not have easy access to mammography. This increases the number of mammogram-detected breast cancers and provides patients with the ability to participate in clinical trials. It also allows us to look at different biomarkers that increase knowledge and impact treatment options. In addition to the mobile unit, proceeds also supported the technology needs of the survivorship center.
2006 Robotic Surgical Equipment — daVinci Robot
The OSUCCC – James has become a leader in robotic surgery, impacting surgeons and patients from around the world. The first robot was in high demand, and the 2006 gift allowed the OSUCCC – James to add a second robot to its surgical lineup, giving patients and doctors more access to the latest surgical technology. It not only allows us to provide minimally invasive treatment for multiple cancers, but also positions the OSUCCC – James to expand the use of surgical robots to treat a variety of noncancerous conditions at The Ohio State University’s Center for Robotics and Computer-Assisted Surgery.
2005 Stereotactic Radiosurgery & Image-Guided Radiation Therapy
This technology provides nonsurgical treatment to tumor sites outside the brain with pinpoint accuracy to reduce damage to healthy tissue. The equipment complements the Division of Radiation Oncology’s existing stereotactic radiosurgery program, which currently treats only brain tumors.
2004 Robotic Surgical Equipment & Technology
With the acquisition of this technology, the OSUCCC – James successfully recruited world-class experts to its robotics and minimally invasive urological surgery program. Surgeons have been able to perform procedures with greater precision and dexterity, allowing patients to recover more quickly, with minimal pain and an earlier return to normal activity.
2003 Intra-Operative MRI system
The physicians of the neurological surgery department are able to better diagnose and treat certain types of cancer with this intra-operative technology unlike any other in central Ohio. This system provides a valuable adjunct to standard neurological care, allowing the surgeon full access to the patient and providing state-of-the-art imaging during surgery.
2002 PET/CT Scanner
The acquisition of a Siemens PET/CTmscanner combined the imaging technologies of positron emission tomography (PET) and computer tomography (CT) to offer the ultimate imaging performance for improved diagnosis and treatment in oncology, neurology and cardiology.